000 01315 a2200337 4500
005 20250516172835.0
264 0 _c20131119
008 201311s 0 0 ger d
022 _a1439-4413
024 7 _a10.1055/s-0033-1349501
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWendtner, C-M
245 0 0 _a[Chemotherapy-free treatment of chronic lymphocytic leukemia?].
_h[electronic resource]
260 _bDeutsche medizinische Wochenschrift (1946)
_cOct 2013
300 _a2104-6 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xtherapeutic use
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aBiological Products
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrugs, Investigational
_xadverse effects
650 0 4 _aHumans
650 0 4 _aLenalidomide
650 0 4 _aLeukemia, Lymphocytic, Chronic, B-Cell
_xdrug therapy
650 0 4 _aMolecular Targeted Therapy
_xmethods
650 0 4 _aRituximab
650 0 4 _aThalidomide
_xanalogs & derivatives
773 0 _tDeutsche medizinische Wochenschrift (1946)
_gvol. 138
_gno. 41
_gp. 2104-6
856 4 0 _uhttps://doi.org/10.1055/s-0033-1349501
_zAvailable from publisher's website
999 _c23134767
_d23134767